New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

Researchers at the Lawson Health Research Institute, part of St. Joseph’s Health Care London, are studying Ambroxol, a cough ...

Groundbreaking research by Sydney University found a new brain protein involved in Parkinson’s disease and a way to modify it ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Clinical Trials Arena · My Ocean Production / Shutterstock. A Parkinson’s disease drug has been effective in reducing the symptoms of treatment-resistant depression. Led by the UK's University of ...

An active ingredient in cough medicines since 1979 has shown promise as a treatment for neuropsychiatric symptoms in ...